title: Maintenance rituximab after autologous stem cell transplant for high-risk B-cell lymphoma induces prolonged and severe hypogammaglobulinemia.
authors.forename: S H
authors.initials: SH
authors.lastname: Lim
authors.forename: Y
authors.initials: Y
authors.lastname: Zhang
authors.forename: Z
authors.initials: Z
authors.lastname: Wang
authors.forename: W V
authors.initials: WV
authors.lastname: Esler
authors.forename: D
authors.initials: D
authors.lastname: Beggs
authors.forename: B
authors.initials: B
authors.lastname: Pruitt
authors.forename: P
authors.initials: P
authors.lastname: Hancock
authors.forename: M
authors.initials: M
authors.lastname: Townsend
mesh_terms: D000361:Agammaglobulinemia / Q000139:chemically induced*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D016393:Lymphoma, B-Cell / Q000150:complications / Q000628:therapy*; D008297:Male; D000069283:Rituximab; D014182:Transplantation, Autologous
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D000069283:Rituximab